Loading...
Thumbnail Image
Publication

COVID-19 Vaccination Timing, Relative to Acute COVID-19, and Subsequent Risk of Long COVID [preprint]

Butzin-Dozier, Zachary
Ji, Yunwen
Wang, Lin-Chiun
Anzalone, A Jerrod
Coyle, Jeremy
Phillips, Rachael V
Patel, Rena C
Sun, Jing
Hurwitz, Eric
Deshpande, Sarang
... show 5 more
Embargo Expiration Date
Abstract

Objectives: Long COVID is a debilitating condition that impacts millions of Americans, but patients and clinicians have little information on how to prevent this disorder. Vaccination is a vital tool in preventing acute COVID-19 and may confer additional protection against Long COVID. There is limited evidence regarding the optimal timing of COVID-19 vaccination (i.e., vaccination schedule) to minimize the risk of Long COVID.

Methods: We applied Longitudinal Targeted Maximum Likelihood Estimation to electronic health record (EHR) data from a retrospective cohort of patients vaccinated against COVID-19 between December 2021 and September 2022. We evaluated the association between binary COVID-19 vaccination status (two or more doses vs. zero doses) and 12-month Long COVID risk among patients diagnosed with acute COVID-19 between December 2021 and September 2022. In addition, we compared the 12-month cumulative risk of Long COVID (ICD-10 code U09.9) among patients diagnosed with acute COVID-19 one to three months after vaccination, three to five months after vaccination, or five to seven months after vaccination while adjusting for relevant high-dimensional baseline and time-dependent covariates.

Results: We analyzed EHR data from a retrospective cohort of 1,558,018 patients. In our binary cohort (n = 519,980), we found that vaccinated patients had a lower risk of Long COVID than unvaccinated patients (adjusted marginal risk ratio 0.84 (0.81, 0.88)). In our longitudinal cohort (n = 1,085,291), we did not find a significant difference in Long COVID risk comparing patients who were diagnosed with acute COVID-19 one to three months after vaccination versus patients who were diagnosed with COVID-19 three to five months (adjusted marginal risk ratio 0.93 (95% CI 0.62, 1.41) or 5 to 7 months (adjusted marginal risk ratio 1.06 (95% CI 0.72, 1.56)) after vaccination.

Conclusions: We found that COVID-19 vaccination before SARS-CoV-2 infection was protective against Long COVID, and we did not find that this protection significantly waned within 7 months after vaccination. These findings suggest that COVID-19 vaccination protects against Long COVID.

Source

Butzin-Dozier Z, Ji Y, Wang LC, Anzalone AJ, Coyle J, Phillips RV, Patel RC, Sun J, Hurwitz E, Deshpande S, Shi JS, Mertens A, van der Laan MJ, Colford JM Jr, Hubbard AE. COVID-19 Vaccination Timing, Relative to Acute COVID-19, and Subsequent Risk of Long COVID. medRxiv [Preprint]. 2025 Apr 23:2025.04.22.25326224. doi: 10.1101/2025.04.22.25326224. PMID: 40313290; PMCID: PMC12045423.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1101/2025.04.22.25326224
PubMed ID
40313290
Other Identifiers
40313290
Notes

This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.

Funding and Acknowledgements
The UMass Center for Clinical and Translational Science (UMCCTS), UL1TR001453, helped fund this study.
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.